Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

Ferri, 2005, Global prevalence of dementia: A Delphi consensus study, Lancet, 366, 2112, 10.1016/S0140-6736(05)67889-0 Langa, 2001, National estimates of the quantity and cost of informal caregiving for the elderly with dementia, J Gen Intern Med., 16, 770, 10.1111/j.1525-1497.2001.10123.x Koedam, 2008, Early-onset dementia is associated with higher mortality, Dement Geriatr Cogn Disord., 26, 147, 10.1159/000149585 Kalaria, 2008, Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors [published correction appears in Lancet Neurol. 2008;7:867], Lancet Neurol., 7, 812, 10.1016/S1474-4422(08)70169-8 Whitehouse, 1997, Dementia drug development: Use of information systems to harmonize global drug development, Psychopharmacol Bull., 33, 129 Hendrie, 1998, Epidemiology of dementia and Alzheimer's disease, Am J Geriatr Psychiatry., 6, S3, 10.1097/00019442-199821001-00002 Launer, 1995, The association between midlife blood pressure levels and late-life cognitive function, JAMA, 274, 1846, 10.1001/jama.1995.03530230032026 Elias, 1993, Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study, Am J Epidemiol., 138, 353, 10.1093/oxfordjournals.aje.a116868 Skoog, 1996, 15-Year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X Kilander, 1998, Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men, Hypertension, 31, 780, 10.1161/01.HYP.31.3.780 Posner, 2002, The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function, Neurology, 58, 1175, 10.1212/WNL.58.8.1175 Kanowski, 1998, Aging, dementia and calcium metabolism, J Neural Transm Suppl., 54, 195, 10.1007/978-3-7091-7508-8_19 Zhang, 1993, Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease [in Chinese], Yao Xue Xue Bao., 28, 641 Landfield, 1994, Increased hippocampal Ca2+ channel activity in brain aging and dementia. Hormonal and pharmacologic modulation, Ann NY Acad Sci., 747, 351, 10.1111/j.1749-6632.1994.tb44422.x Takeda, 2008, The renin-angiotensin system, hypertension and cognitive dysfunc- tion in Alzheimer's disease: New therapeutic potential, Front Biosci., 13, 2253, 10.2741/2839 Kehoe, 2007, Is inhibition of the reninangiotensin system a new treatment option for Alzheimer's disease?, Lancet Neurol., 6, 373, 10.1016/S1474-4422(07)70077-7 Savaskan, 2005, The role of the brain renin-angiotensin system in neurodegenerative disorders, Curr Alzheimer Res., 2, 29, 10.2174/1567205052772740 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Control Clin Trials., 17, 1, 10.1016/0197-2456(95)00134-4 Ohrui, 2004, Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression, Neurology, 63, 1324, 10.1212/01.WNL.0000140705.23869.E9 Yasar, 2005, Calcium channel blockers and risk of AD: The Baltimore Longitudinal Study of Aging, Neurobiol Aging., 26, 157, 10.1016/j.neurobiolaging.2004.03.009 Hajjar, 2005, Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population, J Gerontol A Biol Sci Med Sci., 60, 67, 10.1093/gerona/60.1.67 Khachaturian, 2006, Antihypertensive medication use and incident Alzheimer disease: The Cache County Study, Arch Neurol., 63, 686, 10.1001/archneur.63.5.noc60013 Qiu, 2006, Heart failure and risk of dementia and Alzheimer disease: A populationbased cohort study, Arch Intern Med., 166, 1003, 10.1001/archinte.166.9.1003 Hanon, 2006, Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints, J Hypertens., 24, 2101, 10.1097/01.hjh.0000244961.69985.05 Tzourio, 2003, Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease, Arch Intern Med., 163, 1069, 10.1001/archinte.163.9.1069 Pantoni, 2005, Efficacy and safety of nimodipine in subcortical vascular dementia: A randomized placebo-controlled trial, Stroke, 36, 619, 10.1161/01.STR.0000155686.73908.3e Guo, 1999, Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use, Arch Neurol., 56, 991, 10.1001/archneur.56.8.991 Forette, 2002, The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study [published correction appears in Arch Intern Med. 2003;163:241], Arch Intern Med., 162, 2046, 10.1001/archinte.162.18.2046 Skoog, 2005, Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE), Am J Hypertens., 18, 1052, 10.1016/j.amjhyper.2005.02.013 Peters, 2008, Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A doubleblind, placebo controlled trial, Lancet Neurol., 7, 683, 10.1016/S1474-4422(08)70143-1 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027